Phase II clinical trial of bexarotene gel 1% in psoriasis.

MLA

Breneman, Debra, et al. “Phase II Clinical Trial of Bexarotene Gel 1% in Psoriasis.” Journal of Drugs in Dermatology : JDD, vol. 6, no. 5, May 2007, pp. 501–06. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17679184&authtype=sso&custid=ns315887.

APA

Breneman, D., Sheth, P., Berger, V., Naini, V., & Stevens, V. (2007). Phase II clinical trial of bexarotene gel 1% in psoriasis. Journal of Drugs in Dermatology : JDD, 6(5), 501–506.

Chicago

Breneman, Debra, Pranav Sheth, Vivian Berger, Vahid Naini, and Victor Stevens. 2007. “Phase II Clinical Trial of Bexarotene Gel 1% in Psoriasis.” Journal of Drugs in Dermatology : JDD 6 (5): 501–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=17679184&authtype=sso&custid=ns315887.